I think they have split the studies out over time so there is still the 602n trial with the same 938 from 2021.
Doesn't seem like a red flag. They probably just filed it all as one and combined all participants then split it out at a later date.
Again I am not savvy on trials so maybe someone with more industry knowledge can chime in.
Where we at?, page-285
-
- There are more pages in this discussion • 422 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.55M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $16.18K | 77.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 105193 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 51908 | 4 |
View Market Depth
| Last trade - 10.22am 11/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |